Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterization of hematologic malignancies by flow cytometry

B Barlogie, J Latreille, E J Freireich

    Blood Cells
    |January 1, 1980
    PubMed
    Summary

    Flow cytometry detects DNA content abnormalities in hematologic malignancies, with higher rates in lymphomas and myeloma. RNA content analysis further aids in distinguishing leukemia subtypes and normal cells.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

    Leukemia·2018
    Same author

    Drug response prediction in high-risk multiple myeloma.

    Gene·2017
    Same author

    Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

    Nature communications·2017
    Same author

    Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

    Leukemia·2017
    Same author

    NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma.

    Leukemia·2017
    Same author

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

    Blood cancer journal·2017

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Flow cytometry is crucial for analyzing cellular DNA content.
    • Ploidy abnormalities are common in various hematologic malignancies.
    • Solid tumors exhibit a high incidence of ploidy abnormalities.

    Purpose of the Study:

    • To assess the incidence of DNA content abnormalities in hematologic malignancies using flow cytometry.
    • To evaluate the utility of DNA and RNA content analysis for detecting and differentiating cancer cells.
    • To investigate cell separation techniques for enriching aneuploid cells.

    Main Methods:

    • Flow cytometry was used to analyze cellular DNA content in patients with leukemia, lymphoma, and multiple myeloma.
    • Cell separation by centrifugal elutriation was employed to enrich aneuploid cells.

    Related Experiment Videos

  • Biparametric flow cytometry measuring DNA and RNA content was utilized for enhanced detection.

    • Main Results:

    • DNA content abnormalities were found in 37% of 306 hematologic malignancy patients (15% leukemia, 50% lymphoma, 68% myeloma).
    • Centrifugal elutriation enriched aneuploid cells, improving detection in some cases.
    • DNA/RNA content analysis differentiated acute myeloid leukemia from normal bone marrow and acute lymphoblastic leukemia, identifying myeloid precursor cells with similar RNA patterns.

    Conclusions:

    • Flow cytometry is effective in detecting DNA ploidy abnormalities in hematologic malignancies.
    • DNA/RNA content analysis enhances the discriminatory power of flow cytometry for cancer detection and subtyping.
    • Cell separation techniques can improve the detection of aneuploid cells.